Treatment of (NZB x NZW)F1 disease with anti-I-A monoclonal antibodies
- PMID: 6578293
- PMCID: PMC2187363
- DOI: 10.1084/jem.158.4.1350
Treatment of (NZB x NZW)F1 disease with anti-I-A monoclonal antibodies
Abstract
(NZB x NZW)F1 mice spontaneously develop an autoimmune syndrome characterized by a fatal immune complex glomerulonephritis. Administration of monoclonal antibodies specific for an I region gene product (I-Az) of the H-2 haplotype associated with susceptibility to glomerulonephritis in these animals produced a remission in female mice with established renal disease. The results demonstrated that anti-I-A therapy stabilized the level of proteinuria and increased the 1-yr survival rate from 10% to greater than 90% in treated animals relative to control mice. These findings may ultimately have therapeutic potential for the treatment of systemic lupus erythematosus.
Similar articles
-
Dissection of the effects of tumor necrosis factor-alpha and class II gene polymorphisms within the MHC on murine systemic lupus erythematosus (SLE).Int Immunol. 1998 Oct;10(10):1467-72. doi: 10.1093/intimm/10.10.1467. Int Immunol. 1998. PMID: 9796913
-
Interleukin-6 exacerbates glomerulonephritis in (NZB x NZW)F1 mice.Am J Pathol. 1994 May;144(5):927-37. Am J Pathol. 1994. PMID: 8178944 Free PMC article.
-
Dissection of the role of MHC class II A and E genes in autoimmune susceptibility in murine lupus models with intragenic recombination.Proc Natl Acad Sci U S A. 2004 Sep 21;101(38):13838-43. doi: 10.1073/pnas.0405807101. Epub 2004 Sep 10. Proc Natl Acad Sci U S A. 2004. PMID: 15361580 Free PMC article.
-
Mixed haplotypes and autoimmunity.Immunol Today. 1993 Feb;14(2):53-6. doi: 10.1016/0167-5699(93)90058-s. Immunol Today. 1993. PMID: 8447933 Review.
-
Monoclonal anti-Ia antibody therapy in animal models of autoimmune disease.Ciba Found Symp. 1987;129:184-93. doi: 10.1002/9780470513484.ch12. Ciba Found Symp. 1987. PMID: 3315501 Review.
Cited by
-
Genetic analysis of the imperfect association of H-2 haplotype with lupus-like autoimmune disease.Proc Natl Acad Sci U S A. 1989 Oct;86(19):7552-5. doi: 10.1073/pnas.86.19.7552. Proc Natl Acad Sci U S A. 1989. PMID: 2571993 Free PMC article.
-
New therapeutic approaches to autoimmune disease.Springer Semin Immunopathol. 1986;9(1):105-16. doi: 10.1007/BF00201908. Springer Semin Immunopathol. 1986. PMID: 2425440 Review. No abstract available.
-
Production of erythrocyte autoantibodies in NZB mice is inhibited by CD4 antibodies.Clin Exp Immunol. 1994 May;96(2):297-302. doi: 10.1111/j.1365-2249.1994.tb06557.x. Clin Exp Immunol. 1994. PMID: 8187337 Free PMC article.
-
Lactic dehydrogenase virus infection prevents development of anti-nuclear antibody in (NZB x NZW)F1 mice; role of prostaglandin E2 and macrophage Ia antigen expression.Int J Exp Pathol. 1992 Oct;73(5):593-601. Int J Exp Pathol. 1992. PMID: 1419777 Free PMC article.
-
Successful treatment of autoimmunity in NZB/NZW F1 mice with monoclonal antibody to L3T4.J Exp Med. 1985 Feb 1;161(2):378-91. doi: 10.1084/jem.161.2.378. J Exp Med. 1985. PMID: 3919141 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical